MedCity News October 18, 2024
Jan Schulte

Organizations are delivering digital experiences and content to HCPs on a much larger scale than was previously possible. Integrating digital tools will advance things even further and help marketers and MLR teams maintain brand consistency and ensure compliance across digital and content operations.

What a difference a few years make. Previously, digital strategy in the biopharma industry consisted of a series of isolated projects and fragmented channels, websites, and portals. Today, omnichannel digital engagement is the way of doing business, driven by declining in-person access to healthcare professionals (HCPs).

Over this time, the number of digital-savvy HCPs has increased, as physicians prefer to engage biopharma brands in a variety of digital channels. At the center of the industry’s transformation is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Provider
Precision Medicine Hinges On Access To Genetic Counselors
RNA editing: emerging from CRISPR’s shadow
Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D
Dotmatics aims to speed drug development, break data silos with Geneious Luma
1st sickle cell gene therapy patient completes treatment

Share This Article